General Mills Inc: Form 10-Q for the period ended Feb 25, 2024
Filed with the SEC on Mar 20, 2024 and accepted by EDGAR at Mar 20, 2024, 16:07 ET.
Management's discussion and analysis
As filed, 14,893 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
INTRODUCTION
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read in
conjunction with the MD&A included in our Annual Report on Form 10-K for the fiscal year ended May 28, 2023, for important
background regarding, among other things, our key business drivers. Significant trademarks and service marks used in our business
are set forth in
italics
herein. Certain terms used throughout this report are defined in the “Glossary” section below.
We expect the largest factors impacting our performance in fiscal 2024 will be the economic health of consumers, the moderating rate
of input cost inflation, and the increasing stability of the supply chain environment. We anticipate input cost inflation of
approximately 4 percent in fiscal 2024 and expect to generate higher levels of Holistic Margin Management (HMM) cost savings
compared to fiscal 2023.
CONSOLIDATED RESULTS OF OPERATIONS
Third Quarter Results
In the third quarter of fiscal 2024, net sales and organic net sales decreased 1 percent compared to the same period last year. Operating
profit increased 25 percent to $911 million, primarily driven by favorable net price realization and mix, a decrease in certain
compensation and benefits expenses, a favorable change in the mark-to-market valuation of certain commodity positions and grain
inventories, and net recoveries from the fiscal 2023 voluntary recall on certain international
Häagen-Dazs
ice cream products,
partially offset by higher input costs and a decrease in contributions from volume growth. Operating profit margin of 17.9 percent
increased 370 basis points. Adjusted operating profit of $914 million increased 14 percent on a constant-currency basis, primarily
driven by favorable net price realization and mix and a decrease in certain compensation and benefits expenses, partially offset by
higher input costs and a decrease in contributions from volume growth. Adjusted operating profit margin increased 220 basis points to
17.9 percent. Diluted earnings per share of $1.17 increased 27 percent in the third quarter of fiscal 2024. Adjusted diluted earnings per
share of $1.17 increased 22 percent on a constant-currency basis compared to the third quarter of fiscal 2023. See the “Non-GAAP
Measures” section below for a description of our use of measures not defined by GAAP.
A summary of our consolidated financial results for the third quarter of fiscal 2024 follows:
Quarter Ended Feb. 25, 2024
In millions,
except per share
Quarter Ended
Feb. 25, 2024 vs.
Feb. 26, 2023
Percent
of Net
Sales
Constant-
Currency
Growth (a)
Net sales
5,099.2
(1)
Operating profit
910.7
25
17.9
Net earnings attributable to General Mills
670.1
21
Diluted earnings per share
1.17
27
Organic net sales growth rate (a)
(1)
Adjusted operating profit (a)
914.5
13
17.9
14
Adjusted diluted earnings per share (a)
1.17
21
22
(a) See the “Non-GAAP Measures” section below for our use of measures not defined by GAAP.
Consolidated
net sales
were as follows:
Quarter Ended
Feb. 25, 2024
Feb. 25, 2024 vs.
Feb. 26, 2023
Feb. 26, 2023
Net sales (in millions)
5,099.2
(1)
5,125.9
Contributions from volume growth (a)
(2)
pts
Net price realization and mix
2
pts
Foreign currency exchange
Flat
Note: Table may not foot due to rounding.
(a) Measured in tons based on the stated weight of our product shipments.
Net sales in the third quarter of fiscal 2024 decreased 1 percent compared to the same period in fiscal 2023, driven by a decrease in
contributions from volume growth, partially offset by favorable net price realization and mix.
Components of organic net sales growth are shown in the following table:
Quarter Ended Feb. 25, 2024 vs.
Quarter Ended Feb. 26, 2023
Contributions from organic volume growth (a)
(2)
pts
Organic net price realization and mix
2
pts
Organic net sales growth
(1)
pt
Foreign currency exchange
Flat
Acquisition and divestitures
Flat
Net sales growth
(1)
pt
Note: Table may not foot due to rounding.
(a) Measured in tons based on the stated weight of our product shipments.
Organic net sales decreased 1 percent in the third quarter of fiscal 2024 compared to the same period in fiscal 2023, driven by a
decrease in contributions from organic volume growth, partially offset by favorable organic net price realization and mix.
Cost of sales
decreased $69 million to $3,392 million in the third quarter of fiscal 2024 compared to the same period in fiscal 2023.
The decrease was primarily driven by a $74 million decline attributable to lower volume, partially offset by a $46 million increase
attributable to product rate and mix. We recorded a $26 million net increase in cost of sales related to the mark-to-market valuation of
certain commodity positions and grain inventories in the third quarter of fiscal 2024, compared to a $67 million net increase in the
third quarter of fiscal 2023.
Divestitures gain, net
totaled $14 million in the third quarter of fiscal 2023.
Selling, general, and administrative (SG&A) expenses
decreased $156 million to $791 million in the third quarter of fiscal 2024,
compared to the same period in fiscal 2023, primarily driven by a decrease in certain compensation and benefits expenses, net
recoveries from the fiscal 2023 voluntary recall of certain international
Häagen-Dazs
ice cream products , and favorable net corporate
investment activity. SG&A expenses as a percent of net sales in the third quarter of fiscal 2024 decreased 300 basis points compared
to the third quarter of fiscal 2023.
Restructuring, impairment, and other exit costs
totaled $6 million in the third quarter of fiscal 2024, compared to $1 million in the
same period last year. In fiscal 2024, we approved restructuring actions to enhance the go-to-market commercial strategy and
associated organizational structure of our Pet segment, and as a result, we recorded $8 million of restructuring charges in the third
quarter of fiscal 2024. In addition, we recorded a $3 million net recovery of restructuring charges in the third quarter of fiscal 2024
related to actions previously announced (please refer to Note 3 to the Consolidated Financial Statements in Part I, Item 1 of this
report).
Benefit plan non-service income
totaled $19 million in the third quarter of fiscal 2024, compared to $22 million in the same period
last year, primarily reflecting higher interest costs, partially offset by lower amortization of losses.
Interest, net
for the third quarter of fiscal 2024 totaled $122 million, up $23 million from the third quarter of fiscal 2023, primarily
driven by higher interest rates and higher average long-term debt levels.
The
effective tax rate
for the third quarter of fiscal 2024 was 18.5 percent compared to 16.6 percent for the third quarter of fiscal
2023. The 1.9 percentage point increase was primarily due to certain favorable tax components related to the divestitures in fiscal
2023, partially offset by certain nonrecurring discrete tax benefits in the third quarter of fiscal 2024. Our effective tax rate excluding
certain items affecting comparability was 18.4 percent in the third quarter of fiscal 2024, compared to 21.6 percent in the same period
last year (see the “Non-GAAP Measures” section below for a description of our use of measures not defined by GAAP). The 3.2
percentage point decrease was primarily due to certain nonrecurring discrete tax benefits in the third quarter of fiscal 2024.
After-tax earnings from joint ventures
for the third quarter of fiscal 2024
increased to $18 million compared to $13 million in the
same period in fiscal 2023, primarily due to higher net sales driven by favorable net price realization and mix at Cereal Partners
Worldwide (CPW) and discrete tax items at CPW, partially offset by higher input costs at CPW and Häagen-Dazs Japan, Inc. (HDJ).
On a constant-currency basis, after-tax earnings from joint ventures increased 64 percent (see the “Non-GAAP Measures” section
below for a description of our use of measures not defined by GAAP).
The components of our joint ventures’ net sales growth are shown in the following table:
Quarter Ended Feb. 25, 2024 vs.
Quarter Ended Feb. 26, 2023
CPW
HDJ
Total
Contributions from volume growth (a)
(4)
pts
(9)
pts
Net price realization and mix
16
pts
7
pts
Net sales growth in constant currency
11
pts
(2)
pts
9
pts
Foreign currency exchange
(4)
pts
(10)
pts
(5)
pts
Net sales growth
7
pts
(12)
pts
3
pts
Note: Table may not foot due to rounding.
(a) Measured in tons based on the stated weight of our product shipments.
Average diluted shares outstanding
decreased by 26 million in the third quarter of fiscal 2024 from the same period a year ago
primarily due to share repurchases, partially offset by option exercises.
Nine-Month Results
In the nine-month period ended February 25, 2024, net sales and organic net sales increased 1 percent compared to the same period
last year. Operating profit increased 1 percent to $2,652 million, primarily driven by favorable net price realization and mix, a
favorable change in the mark-to-market valuation of certain commodity positions and grain inventories, a decrease in certain
compensation and benefits expense, favorable net corporate investment activity, and net recoveries from the fiscal 2023 voluntary
recall on certain international
Häagen-Dazs
ice cream products compared to recall-related charges in fiscal 2023, partially offset by a
net gain on divestitures in fiscal 2023, higher input costs, a decrease in contributions from volume growth, higher impairment and
restructuring charges, and higher media and advertising expenses. Operating profit margin of 17.5 percent increased 10 basis points
compared to the same period last year. Adjusted operating profit of $2,803 million increased 9 percent on a constant-currency basis,
primarily driven by favorable net price realization and mix and a decrease in certain compensation and benefits expenses, partially
offset by higher input costs and a decrease in contributions from volume growth. Adjusted operating profit margin increased 150 basis
points to 18.5 percent. Diluted earnings per share of $3.33 increased 2 percent in the nine-month period ended February 25, 2024, and
adjusted diluted earnings per share of $3.51 increased 11 percent on a constant-currency basis compared to the same period last year
(see the “Non-GAAP Measures” section below for a description of our use of measures not defined by GAAP).
A summary of our consolidated financial results for the nine-month period ended February 25, 2024, follows:
Nine-Month Period Ended Feb. 25, 2024
In millions,
except per share
Nine-Month
Period Ended
Feb. 25, 2024 vs.
Feb. 26, 2023
Percent of Net
Sales
Constant-
Currency
Growth (a)
Net sales
15,143.3
1
Operating profit
2,652.5
1
17.5
Net earnings attributable to General Mills
1,939.1
(2)
Diluted earnings per share
3.33
2
Organic net sales growth rate (a)
1
Adjusted operating profit (a)
2,802.9
9
18.5
9
Adjusted diluted earnings per share (a)
3.51
10
11
(a) See the “Non-GAAP Measures” section below for our use of measures not defined by GAAP.
Consolidated
net sales
were as follows:
Nine-Month Period Ended
Feb. 25, 2024
Feb. 25, 2024 vs.
Feb. 26, 2023
Feb. 26, 2023
Net sales (in millions)
15,143.3
1
15,064.2
Contributions from volume growth (a)
(3)
pts
Net price realization and mix
3
pts
Foreign currency exchange
Flat
Note: Table may not foot due to rounding.
(a) Measured in tons based on the stated weight of our product shipments.
The 1 percent increase in net sales for the nine-month period ended February 25, 2024, was driven by favorable net price realization
and mix, partially offset by a decrease in contributions from volume growth.
Components of organic net sales growth are shown in the following table:
Nine-Month Period Ended Feb. 25, 2024 vs.
Nine-Month Period Ended Feb. 26, 2023
Contributions from organic volume growth (a)
(3)
pts
Organic net price realization and mix
4
pts
Organic net sales growth
1
pt
Foreign currency exchange
Flat
Acquisition and divestitures
Flat
Net sales growth
1
pt
Note: Table may not foot due to rounding.
(a) Measured in tons based on the stated weight of our product shipments.
Organic net sales increased 1 percent in the nine-month period ended February 25, 2024, driven by favorable organic net price
realization and mix, partially offset by a decrease in contributions from organic volume growth.
Cost of sales
decreased $347 million to $9,900 million in the nine-month period ended February 25, 2024, compared to the same
period in fiscal 2023. The decrease was primarily driven by a $281 million decline due to lower volume, partially offset by a
$202 million increase attributable to product rate and mix. We recorded a $6 million net increase in cost of sales related to the mark-
to-market valuation of certain commodity positions and grain inventories in the nine-month period ended February 25, 2024,
compared to a $266 million net increase in the nine-month period ended February 26, 2023. In the nine-month period ended February
26, 2023, we recorded a $25 million charge related to a voluntary recall on certain international
Häagen-Dazs
ice cream products. In
addition, we recorded $17 million of restructuring charges and $2 million of restructuring initiative project-related costs in cost of
sales in the nine-month period ended February 25, 2024, compared to $2 million of restructuring charges in the same period last year
(please refer to Note 3 to the Consolidated Financial Statements in Part I, Item 1 of this report).
SG&A expenses
decreased $171 million to $2,461 million in the nine-month period ended February 25, 2024, compared to the same
period in fiscal 2023, primarily driven by a decrease in certain compensation and benefits expenses, favorable net corporate
investment activity, and net recoveries from the fiscal 2023 voluntary recall on certain international
Häagen-Dazs
ice cream products
in fiscal 2024, partially offset by higher media and advertising expenses. SG&A expenses as a percent of net sales decreased 130 basis
points in the nine-month period ended February 25, 2024, compared to the same period of fiscal 2023.
Divestitures gain, net
totaled $445 million in the nine-month period ended February 26, 2023, primarily related to the sale of our
Helper main meals and Suddenly Salad side dishes business (please refer to Note 2 to the Consolidated Financial Statements in Part I,
Market risk
As filed, 736 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The estimated maximum potential value-at-risk arising from a one-day loss in fair value for our interest rate, foreign exchange,
commodity, and equity market-risk-sensitive instruments outstanding as of February 25, 2024, was as follows:
In Millions
One-day Risk
of Loss
Change During
Nine-Month
Period Ended
Feb. 25, 2024
Analysis of Change
Interest rate instruments
55
(11)
Lower interest rate volatility
Foreign currency instruments
26
(11)
Net price stability in portfolio
Commodity instruments
5
(3)
Decrease in commodity prices
Equity instruments
2
(1)
Immaterial
For additional information, see Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended May 28, 2023.
Controls and procedures
As filed, 1,285 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial
Officer, have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule
13a-15(e) under the Securities Exchange Act of 1934). Based on our evaluation, our Chief Executive Officer and Chief Financial
Officer have concluded that, as of February 25, 2024, our disclosure controls and procedures were effective to ensure that information
required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is (1) recorded, processed,
summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2)
accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner
that allows timely decisions regarding required disclosure.
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act
of 1934) during the quarter ended February 25, 2024, that materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-02-25. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-11-27 to 2024-02-25 | $5.10bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-05-29 to 2024-02-25 | $15.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-11-27 to 2024-02-25 | $3.39bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-05-29 to 2024-02-25 | $9.90bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-11-27 to 2024-02-25 | $790.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-05-29 to 2024-02-25 | $2.46bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-11-27 to 2024-02-25 | $910.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-05-29 to 2024-02-25 | $2.65bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-11-27 to 2024-02-25 | $121.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-05-29 to 2024-02-25 | $356.5m | us-gaap:InterestExpense |
| Income tax | 3 months2023-11-27 to 2024-02-25 | $149.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-05-29 to 2024-02-25 | $458.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-11-27 to 2024-02-25 | $670.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-05-29 to 2024-02-25 | $1.94bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-11-27 to 2024-02-25 | $1.17 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-05-29 to 2024-02-25 | $3.33 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-11-27 to 2024-02-25 | $1.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-05-29 to 2024-02-25 | $3.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-11-27 to 2024-02-25 | 572,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-05-29 to 2024-02-25 | 582,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-05-29 to 2024-02-25 | $2.44bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-05-29 to 2024-02-25 | $485.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-05-29 to 2024-02-25 | $1.03bn | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2023-05-29 to 2024-02-25 | $1.60bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-02-25 | $588.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-02-25 | $4.65bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-02-25 | $30.86bn | us-gaap:Assets |
| Current liabilities | At period end2024-02-25 | $7.06bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-02-25 | $21.17bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2024-02-25 | $686.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-02-25 | $9.44bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-24-072690. Last ingested by Listed: Nov 3, 2026, 23:01 ET. Listed shows no prices and gives no investment advice.